Business Description
Cidara Therapeutics Inc
NAICS : 325412
SIC : 2834
Compare
Compare
Traded in other countries / regions
20D.GermanyCDTX.USA IPO Date
2015-04-15Description
Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. Its other product candidates include CD377, CD388, RSV AVC, HIV AVC, and SARS-CoV-2 AVC.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 24.85 | |||||
| Equity-to-Asset | -0.06 | |||||
| Debt-to-Equity | -0.45 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -11.06 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.6 | |||||
| 3-Year EBITDA Growth Rate | 33.6 | |||||
| 3-Year EPS without NRI Growth Rate | 32 | |||||
| 3-Year FCF Growth Rate | 24.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.19 | |||||
| 9-Day RSI | 30.77 | |||||
| 14-Day RSI | 37.1 | |||||
| 6-1 Month Momentum % | 140.26 | |||||
| 12-1 Month Momentum % | 74.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | |||||
| Quick Ratio | 1.5 | |||||
| Cash Ratio | 1.09 | |||||
| Days Sales Outstanding | 33.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -46.23 | |||||
| Net Margin % | -46.35 | |||||
| ROE % | -602.44 | |||||
| ROA % | -52.35 | |||||
| ROIC % | -125.83 | |||||
| ROC (Joel Greenblatt) % | -1505.78 | |||||
| ROCE % | -119.83 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 4.14 | |||||
| PS Ratio | 1.46 | |||||
| EV-to-EBIT | -2.42 | |||||
| EV-to-EBITDA | -2.52 | |||||
| EV-to-Revenue | 1.12 | |||||
| EV-to-Forward-Revenue | 0.77 | |||||
| EV-to-FCF | -2.51 | |||||
| Earnings Yield (Greenblatt) % | -41.32 |
How Cidara Therapeutics Inc (CDTX) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDTX
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 64.288 | ||
| EPS (TTM) ($) | -0.48 | ||
| Beta | 1.07 | ||
| Volatility % | 100.87 | ||
| 14-Day RSI | 37.1 | ||
| 14-Day ATR ($) | 0.232103 | ||
| 20-Day SMA ($) | 1.64525 | ||
| 12-1 Month Momentum % | 74.89 | ||
| 52-Week Range ($) | 0.4 - 2.1 | ||
| Shares Outstanding (Mil) | 89.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cidara Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cidara Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cidara Therapeutics Inc Frequently Asked Questions
What is Cidara Therapeutics Inc(CDTX)'s stock price today?
The current price of CDTX is $1.16. The 52 week high of CDTX is $2.10 and 52 week low is $0.40.
When is next earnings date of Cidara Therapeutics Inc(CDTX)?
The next earnings date of Cidara Therapeutics Inc(CDTX) is 2023-05-11 Est..
Does Cidara Therapeutics Inc(CDTX) pay dividends? If so, how much?
Cidara Therapeutics Inc(CDTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
